Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Lupeng Pharma Closes 2nd $35 Million Pre-B Tranche for Small Molecule Drugs
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Multinational pharma held to a higher standard in China